Thesis is the company that offers a customized approach to cognitive performance products based on your unique brain chemistry.

Is it a placebo?  Is it not a placebo?  Thesis and Unilever think the answer is no.  The investment was interestingly led by a partner at Unilever Ventures which gives the brand a potential future exit as well.  The company originally came out of New York-based accelerator XRC.

Business Wire: Thesis, the First High Quality and Customized Nootropics Solution, Raises Total of $13.5 Million in Funding